Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets
previously Generic Genvoya 150mg/150mg/200mg/10mg tablets
- SNOMED code
31145211000001103- Named
- Active compound
- Elvitegravir + Cobicistat + Emtricitabine + Tenofovir alafenamide
- Preferred name basis
- Other
previously
Other - Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Elvitegravir
— 150 mg
based on ingredient substance
Cobicistat — 150 mg based on ingredient substance
Emtricitabine — 200 mg based on ingredient substance
Tenofovir alafenamide fumarate, ID: 715220007 — 10 mg based on base substance - Form & Route
- tablet.oral
Oral tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Genvoya 150mg/150mg/200mg/10mg tablets (Gilead Sciences Ltd)
Genvoya 150mg/150mg/200mg/10mg tablets
- SNOMED code
31073011000001101- Supplier
- Gilead Sciences Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Genvoya 150mg/150mg/200mg/10mg tablets (Gilead Sciences Ltd) 30 tablet31073111000001100 ref. pack | 💯 Available Legal category: POM | 0539150714518505391507145192End: | NHS Indicative Price £879.51 | • Hospital |
| — |
Reference packs
Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets 30 tablet
- SNOMED code
31072911000001109- Quantity and unit
- 30 tablet
- Packs